Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles
- 18 February 2008
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 126 (1), 77-84
- https://doi.org/10.1016/j.jconrel.2007.11.002
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Tumor-targeted Delivery of siRNA by Self-assembled NanoparticlesMolecular Therapy, 2008
- Mechanistic studies of sequential injection of cationic liposome and plasmid DNAMolecular Therapy, 2006
- Sequence-Specific Knockdown of EWS-FLI1 by Targeted, Nonviral Delivery of Small Interfering RNA Inhibits Tumor Growth in a Murine Model of Metastatic Ewing's SarcomaCancer Research, 2005
- Tumor Growth Inhibition by Simultaneously Blocking Epidermal Growth Factor Receptor and Cyclooxygenase-2 in a Xenograft ModelClinical Cancer Research, 2005
- Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivoProceedings of the National Academy of Sciences, 2005
- Gene silencing in primary and metastatic tumors by small interfering RNA delivery in mice: Quantitative analysis using melanoma cells expressing firefly and sea pansy luciferasesJournal of Controlled Release, 2005
- Nanoparticle and targeted systems for cancer therapyAdvanced Drug Delivery Reviews, 2004
- In vivo gene transfer via intravenous administration of cationic lipid–protamine–DNA (LPD) complexesGene Therapy, 1997
- CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract.Journal of Clinical Investigation, 1997
- Organ-Specific Modulation of Steady-State mdr Gene Expression and Drug Resistance in Murine Colon Cancer CellsJNCI Journal of the National Cancer Institute, 1994